We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Reimplanting Lab-Grown Patient Cartilage Accelerates Healing After Hip Surgery

By HospiMedica International staff writers
Posted on 26 Aug 2025

Patients undergoing hip surgery for femoral acetabular impingement (FAI) often face persistent pain and joint problems caused by a bony bump called a CAM lesion that grinds against the hip socket. More...

Current procedures involve removing the lesion and discarding its cartilage covering, missing a potential opportunity to aid recovery. Researchers are now exploring whether this cartilage can be repurposed to promote healing after surgery.

Researchers at the University of Missouri (Columbia, MO, USA) collected cartilage removed during hip surgeries and investigated its potential to be used therapeutically. Their work explored whether chondrocytes, or cartilage cells, harvested during surgery could be cultured and grown in the lab. Their approach envisions growing the patient’s own cells for later reimplantation into the hip joint.

Their study demonstrated that these cartilage cells remain viable when cultured, opening new possibilities for regenerative applications. By proving their ability to grow chondrocytes outside the body, the research provides a foundation for exploring their use in clinical settings. The study results were published in the journal Archives of Orthopedic and Trauma Surgery.

This breakthrough could enable surgeons to return lab-grown cartilage to the hip joint, potentially reducing pain and improving recovery times for patients with FAI. In addition to hip surgery, the approach could have broader implications for orthopedic care by rethinking how discarded tissue might instead be used as a resource for repair. Future research will focus on translating these findings into clinical practice through further trials and refinement.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.